The information on this website is intended for an international healthcare professional audience outside of the United States, United Kingdom, and Ireland only.
Copyright 2019 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are trademarks of Takeda Pharmaceutical Company Limited. Revestive is a registered trademark of Shire,
now part of Takeda. Shire remains the MA holder for Revestive.
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are
asked to report any suspected adverse reactions via the national reporting system found under Section 4.8 of the Summary of Product Characteristics.
This website is intended to provide information to an international healthcare audience outside the USA and UK. It contains information on Revestive and
Teduglutide, which is based on the Summary of Product Characteristics (SPC) as approved by the European Commission.
This website is not intended to be used to report adverse events or product quality complaints. If you would to report an adverse event or product quality
complaint, please contact us at firstname.lastname@example.org